NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
By Elana Gotkine HealthDay Reporter
MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns, according to a study published online June 24 in JAMA Network Open.
Henning Clausen, M.D., from Lund University in Sweden, and colleagues examined the performance of two diagnostic tests using minimal amounts of dried blood spots (DBS) to identify high-risk CHD in a Swedish cohort of neonates. Automated quantitative tests for NT-proBNP and IL-1 RL1 (formerly known as soluble ST2) were compared against established CHD screening methods among 313 newborns.
The DBS samples analyzed included 217 CHD cases and 96 controls; of the CHD cases, 89.3 percent (188 cases) were high-risk types, of which 38.8 percent (73 cases) were suspected prenatally. The researchers found that 94 (50.0 percent) of the high-risk cases passed pulse oximetry screening and 36 (19.1 percent) were discharged after birth without diagnoses. Compared with existing screening methods, combining NT-proBNP and IL-1 RL1 tests performed well, enabling additional identification of asymptomatic babies, with a receiver operating characteristic area under the curve of 0.95.
"Tests were accurate and performed well in differentiating healthy controls from high-risk CHD cases," the authors write. "This warrants prospective evaluation to improve early diagnosis of CHD in this vulnerable population of newborns."
Two authors disclosed ties to the pharmaceutical industry; one reported having a patent pending for screening products.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
Maternal Distress Tied to Changes in Brain Growth of Offspring
FRIDAY, June 21, 2024 -- Regional neonatal brain volumes are associated with elevated maternal psychological distress, according to a study published online June 20 in JAMA...
Drug-Related Infant Mortality Increased Significantly From 2018 to 2022
WEDNESDAY, June 19, 2024 -- Drug-related infant mortality increased significantly from 2018 to 2022, according to a study published online May 22 in the Journal of Perinatal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.